Healthcare Policies to Watch in the New Trump Administration
Kate Hardey speaks with The Wall Street Journal about potential policy changes that could impact healthcare entrepreneurs under the incoming Republican government, such as how the FDA’s existing LDT policy may evolve during the Trump administration.
